HomeKYTX • NASDAQ
add
Kyverna Therapeutics Inc
Previous close
$8.13
Day range
$8.07 - $9.10
Year range
$1.78 - $13.67
Market cap
507.29M USD
Avg Volume
2.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.27M | -13.65% |
Net income | -36.79M | -6.65% |
Net profit margin | — | — |
Earnings per share | -0.85 | -6.25% |
EBITDA | -38.46M | -0.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 171.14M | -46.78% |
Total assets | 187.16M | -44.82% |
Total liabilities | 35.21M | -3.50% |
Total equity | 151.95M | — |
Shares outstanding | 43.80M | — |
Price to book | 2.34 | — |
Return on assets | -46.81% | — |
Return on capital | -55.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -36.79M | -6.65% |
Cash from operations | -43.32M | -57.59% |
Cash from investing | 22.56M | 3,236.83% |
Cash from financing | 1.49M | 1,078.95% |
Net change in cash | -19.28M | 28.51% |
Free cash flow | -28.65M | -102.66% |
About
Founded
2018
Headquarters
Website
Employees
129
